MLchartDataset catalogue

FOLFIRI-bevacizumab

Term · Oncology and biomedicine · MLC-T-ONC-003288

A chemotherapy combination used as an initial treatment of colorectal cancer that has spread. It includes the drugs leucovorin (folinic acid), fluorouracil, irinotecan hydrochloride, and bevacizumab. Also called FOLFIRI-Avastin regimen and FOLFIRI-bevacizumab regimen.

Table 1. Record
IdentifierMLC-T-ONC-003288
FieldOncology and biomedicine
SynonymsFOLFIRI-Avastin regimen; FOLFIRI-bevacizumab regimen
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-003288",
  "term": "FOLFIRI-bevacizumab",
  "field": "Oncology and biomedicine",
  "definition": "A chemotherapy combination used as an initial treatment of colorectal cancer that has spread. It includes the drugs leucovorin (folinic acid), fluorouracil, irinotecan hydrochloride, and bevacizumab. Also called FOLFIRI-Avastin regimen and FOLFIRI-bevacizumab regimen.",
  "synonyms": [
    "FOLFIRI-Avastin regimen",
    "FOLFIRI-bevacizumab regimen"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/folfiri-bevacizumab/"
}

Record 7,526 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.